[Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent. (4).--Anti-inflammatory activity of N-5' (author's transl)].
D000818:Animals; D000893:Anti-Inflammatory Agents; D002199:Capillary Permeability / Q000187:drug effects; D002351:Carrageenan; D003911:Dextrans; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D006099:Granuloma / Q000188:drug therapy; D006633:Histamine Antagonists; D006821:Hyaluronoglucosaminidase / Q000037:antagonists & inhibitors; D008297:Male; D010047:Ovalbumin; D051381:Rats; D013997:Time Factors; D062367:ortho-Aminobenzoates / Q000494:pharmacology* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D003911:Dextrans; D006633:Histamine Antagonists; D062367:ortho-Aminobenzoates; D002351:Carrageenan; D010047:Ovalbumin; D006821:Hyaluronoglucosaminidase